Kilian Maire

Profile

Immunologist with deep expertise in Th2 lymphocyte biology, in vivo models, cellular signalling, and high-throughput molecular screening. Proven track record of high-impact scientific output and award-winning presentations, combined with leadership as founder & CEO of two ventures. Mastery of flow cytometry, live imaging, primary T-cell manipulation and single-cell/bulk TCR repertoire analysis, bridged with computer vision, AI and product development for regulated laboratory environments.

Experience

Postdoctoral Researcher

University of Copenhagen, Skin Immunology Research Center (LEO Foundation)
2025–present
Dir. Pr. Jonathan Coquet · Copenhagen, Denmark
  • Investigate T-cell receptor (TCR) repertoire dynamics in inflammatory and allergic responses across human and mouse models.
  • Integrate single-cell and bulk TCR repertoire analyses with high-dimensional immunophenotyping and functional assays.
  • Link clonal diversity to T-cell differentiation, tissue adaptation and pathogenic potential.

Founder & CEO

Biotraxion
2025–present
Traceability platform for preclinical laboratories
  • Led end-to-end product vision from scientific problem definition to system architecture, regulatory strategy and go-to-market.
  • Oversaw R&D across embedded systems, computer vision, AI and cloud software, focused on compliance and traceability in regulated environments.
  • Drove business strategy, fundraising materials, IP & FTO analysis, and partnerships with academic labs, hospitals and biotech/pharma.

Founder & CEO

KIMA Holding
2025–present
Holding structure behind the ventures

PhD, Life Sciences & Health (Immunology)

INFINITY, INSERM / CNRS, University of Toulouse
2021–2024
Supervisors: Pierre Lutz & Isabelle Lamsoul
  • Characterised a novel pharmacological target in Th2-lymphocyte-mediated atopic disease, notably asthma.
  • Ran an in vivo mouse model of airway inflammation, live imaging, and high-throughput drug-candidate screening and validation.
  • Outputs: first-author Nature Communications paper and a European patent on rewiring Th2 responses.

MSc Research Internship

INFINITY (INSERM), Lesourne / Dupré team
2019–2021
  • High-throughput screening of 1500+ small molecules; identified 2 compounds increasing filamin levels in Th2 lymphocytes.
  • Techniques: plasmid transfection, ex vivo T-cell generation, flow cytometry, Western blot, RT-qPCR, ELISA.

BSc Research Internship

CPTP (INSERM), Guéry team
2017–2019
  • Characterised the role of Caᵥ1.2/Caᵥ1.3 calcium channels in Th2 functions in physiological and pathological contexts.

Laboratory Technician Diploma

Cancer Biology Resource Center, IUCT
2015–2017
  • Built a prostatic adenocarcinoma biobank and characterised prognostic factors by immunohisto/cytochemistry.

Science Teaching

Acadomia & University of Toulouse
2020–2024
Private tutoring and university teaching (Licence / Master)

Education & Certification

PhD, Life Sciences & Health

University of Toulouse · Immunology
2021–2024

Master's Degree

University of Toulouse
2019–2021

Bachelor's Degree

University of Toulouse
2017–2019

Laboratory Technician Diploma

Specialisation: Life Sciences
2015–2017

FELASA Certification

Use & protection of laboratory animals
2023

Baccalauréat

Specialisation: Life Sciences
2015

Selected Publications & IP

Awards & Honors

Skills

Wet-lab & Immunology
Flow cytometryPrimary T-cell manipulationIn vivo mouse models Live imagingRT-qPCRWestern blotELISA Plasmid transfectionHigh-throughput screeningImmunohisto/cytochemistry
Computational & AI
TCR / BCR repertoire analysisHigh-dimensional immunophenotyping Single-cell & bulk analysisPythonAgentic AI methods Computer visionIMGT
Leadership & Business
Company buildingProduct visionFundraising IP & FTOScientific communicationProject leadershipTeaching
Languages
French, nativeEnglish, fluent / professional